Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
Vale SA
VALE
KB Home
KBH
Apple
AAPL
US Stock MarketDetailed Quotes
VSTM Verastem
- 5.9700
- -0.1400-2.29%
Close Feb 14 16:00 ET
- 6.0000
- +0.0300+0.50%
Post 17:16 ET
265.70MMarket Cap-1.90P/E (TTM)
6.1650High5.8707Low409.33KVolume6.1400Open6.1100Pre Close2.45MTurnover1.35%Turnover RatioLossP/E (Static)44.51MShares13.820052wk High23.98P/B181.24MFloat Cap2.100052wk Low--Dividend TTM30.36MShs Float225.8400Historical High--Div YieldTTM4.82%Amplitude2.1000Historical Low5.9800Avg Price1Lot Size
About Verastem Company
Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.
Company Profile
SymbolVSTM
Company NameVerastem
Listing DateJan 27, 2012
Issue Price10.00
Founded2010
CEOMr. Daniel Paterson
MarketNASDAQ
Employees73
Fiscal Year Ends12-31
Address117 Kendrick Street,Suite 500
CityNeedham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02494
Phone1-781-292-4200
Websitehttp://www.verastem.com
Company Executives
- Name
- Position
- Salary
- Daniel Paterson
- Director, President and Chief Executive Officer
- 3.63M
- Daniel Calkins
- Chief Financial Officer and Chief Accounting Officer
- 622.56K
- Matthew E. Ros
- Chief Operating Officer
- --
- Robert Gagnon, M.B.A.
- Director
- 64.29K
- Brian M. Stuglik, R.Ph.
- Director
- 2.02M
- Michelle Robertson
- Independent Director
- 84.29K
- Dr. Michael Glen Kauffman, M.D.,PhD
- Lead Independent Director
- 124.29K
- John H. Johnson
- Independent Director
- 81.29K
- Dr. Eric K. Rowinsky,M.D.
- Independent Director
- 89.29K
- Anil Kapur
- Independent Director
- 81.75K
- Dr. Karin Tollefson
- Independent Director
- 93.49K
- Dr. Paul Bunn, M.D.
- Independent Director
- 74.29K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.